These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 37606164

  • 1. A Pan-Cancer Analysis to Provide Insight into the Immunological Role and Prognostic Value of HTRA3.
    Xu Q, Wang J, Wang J, Zhu Y, Chen B, Guo R, Qian Y, Yuan H, Liu F.
    Crit Rev Eukaryot Gene Expr; 2023; 33(8):57-75. PubMed ID: 37606164
    [Abstract] [Full Text] [Related]

  • 2. Antagonism between HTRA3 and TGFβ1 Contributes to Metastasis in Non-Small Cell Lung Cancer.
    Zhao J, Feng M, Liu D, Liu H, Shi M, Zhang J, Qu J.
    Cancer Res; 2019 Jun 01; 79(11):2853-2864. PubMed ID: 30940659
    [Abstract] [Full Text] [Related]

  • 3. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer.
    Forse CL, Rahimi M, Diamandis EP, Assarzadegan N, Dawson H, Grin A, Kennedy E, O'Connor B, Messenger DE, Riddell RH, Kirsch R, Karagiannis GS.
    Exp Mol Pathol; 2017 Aug 01; 103(1):94-100. PubMed ID: 28716573
    [Abstract] [Full Text] [Related]

  • 4. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
    Chen P, Xu J, Cui Z, Wu S, Xie T, Zhang X.
    Front Immunol; 2023 Aug 01; 14():1071675. PubMed ID: 36761737
    [Abstract] [Full Text] [Related]

  • 5. A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.
    Chen R, Wu W, Chen SY, Liu ZZ, Wen ZP, Yu J, Zhang LB, Liu Z, Zhang J, Luo P, Zeng WJ, Cheng Q.
    Front Immunol; 2022 Aug 01; 13():831542. PubMed ID: 35979347
    [Abstract] [Full Text] [Related]

  • 6. Changes in expression of human serine protease HtrA1, HtrA2 and HtrA3 genes in benign and malignant thyroid tumors.
    Zurawa-Janicka D, Kobiela J, Galczynska N, Stefaniak T, Lipinska B, Lachinski A, Skorko-Glonek J, Narkiewicz J, Proczko-Markuszewska M, Sledzinski Z.
    Oncol Rep; 2012 Nov 01; 28(5):1838-44. PubMed ID: 22923201
    [Abstract] [Full Text] [Related]

  • 7. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C, Sun LS, Xing F, Niu N, Gao HL, Dai JW, Zhou N, Jiang BC.
    Front Oncol; 2020 Nov 01; 10():603480. PubMed ID: 33425760
    [Abstract] [Full Text] [Related]

  • 8. High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non-small-cell lung cancer.
    Zhao J, Zhang J, Zhang X, Feng M, Qu J.
    Oncotarget; 2016 Jun 28; 7(26):40725-40734. PubMed ID: 27166271
    [Abstract] [Full Text] [Related]

  • 9. Expression of human HtrA1, HtrA2, HtrA3 and TGF-beta1 genes in primary endometrial cancer.
    Narkiewicz J, Lapinska-Szumczyk S, Zurawa-Janicka D, Skorko-Glonek J, Emerich J, Lipinska B.
    Oncol Rep; 2009 Jun 28; 21(6):1529-37. PubMed ID: 19424634
    [Abstract] [Full Text] [Related]

  • 10. HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the PTEN/PI3K/AKT pathway.
    Tong Z, Shen Y, Yuan Q, Yu H.
    Biochim Biophys Acta Mol Cell Res; 2023 Oct 28; 1870(7):119553. PubMed ID: 37527738
    [Abstract] [Full Text] [Related]

  • 11. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
    Jia Y, Guo B, Zhang W, Wang F, Zhang Y, Zhang Q, Li E.
    Front Oncol; 2023 Oct 28; 13():1110207. PubMed ID: 37427102
    [Abstract] [Full Text] [Related]

  • 12. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S, Sun L, Hou P, Liu K, Wu J.
    Front Immunol; 2022 Oct 28; 13():944898. PubMed ID: 36148220
    [Abstract] [Full Text] [Related]

  • 13. The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis.
    Cheng L, Zou X, Wang J, Zhang J, Mo Z, Huang H.
    Front Surg; 2022 Oct 28; 9():1117307. PubMed ID: 36713654
    [Abstract] [Full Text] [Related]

  • 14. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer.
    Cui G, Wang C, Lin Z, Feng X, Wei M, Miao Z, Sun Z, Wei F.
    Bioengineered; 2021 Dec 28; 12(1):4828-4840. PubMed ID: 34346294
    [Abstract] [Full Text] [Related]

  • 15. Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A Comprehensive Pan-Cancer Analysis.
    Wang DD, Xu WX, Chen WQ, Li L, Yang SJ, Zhang J, Tang JH.
    J Oncol; 2022 Dec 28; 2022():9133636. PubMed ID: 36304987
    [Abstract] [Full Text] [Related]

  • 16. Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker.
    Meng W, Jiang Z, Zhang X, Cai B, Ma L, Guan Y.
    Comput Math Methods Med; 2022 Dec 28; 2022():3119721. PubMed ID: 36466552
    [Abstract] [Full Text] [Related]

  • 17. RecQ mediated genome instability 2 (RMI2): a potential prognostic and immunological biomarker for pan-cancers.
    Wei W, Ying X, Chen L, Sun Q, Lu X, Xia Y, Xu R, Zhu Z, Zhang D, Tang Q, Li L, Xie J, Yu H.
    Aging (Albany NY); 2022 May 12; 14(9):4107-4136. PubMed ID: 35552266
    [Abstract] [Full Text] [Related]

  • 18. Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2.
    Nie GY, Hampton A, Li Y, Findlay JK, Salamonsen LA.
    Biochem J; 2003 Apr 01; 371(Pt 1):39-48. PubMed ID: 12513693
    [Abstract] [Full Text] [Related]

  • 19. A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2.
    Wu X, Chen H, You C, Peng Z.
    Hereditas; 2023 May 11; 160(1):21. PubMed ID: 37170390
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S, Chen X, Fang J, Chu H, Fang S, Zeng L, Ma H, Zhang T, Chen Y, Wang T, Zhang X, Shen T, Zheng Y, Xu D, Lu Z, Pan Y, Liu Y.
    Front Immunol; 2023 May 11; 14():1155182. PubMed ID: 37275857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.